Clinical Trials Directory

Trials / Completed

CompletedNCT06704178

A Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.

A Randomized Double-blind Placebo-controlled Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
NuBest · Industry
Sex
All
Age
10 Years – 16 Years
Healthy volunteers
Accepted

Summary

A 6-month virtual two-armed randomized double-blind placebo-controlled clinical trial. Participants will take NuBest Tall Growth Protein Powder or a placebo daily. Parents will complete questionnaires at baseline and monthly, and children will undergo cognitive assessments and height/weight measurements at specified intervals.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNuBest Tall Growth Protein PowderNuBest Tall Growth Protein Powder includes a proprietary blend of vitamins, minerals, and probiotics designed to enhance children's health outcomes.
DIETARY_SUPPLEMENTPlacebo PowderThe placebo powder is designed to mimic the appearance and taste of the NuBest Tall Growth Protein Powder but does not contain the active ingredients.

Timeline

Start date
2024-06-12
Primary completion
2025-02-16
Completion
2025-02-16
First posted
2024-11-26
Last updated
2025-07-24
Results posted
2025-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06704178. Inclusion in this directory is not an endorsement.